Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay detects DNA breakage by labeling the free 3ʹ-hydroxyl termini. Given that genomic DNA breaks arise during early and late stages of apoptosis, TUNEL staining continues to be widely used as a measure of apoptotic cell death. The advantages of the assay include its relative ease of performance and the broad availability of TUNEL assay kits for various applications, such as single-cell analysis of apoptosis in cell cultures and tissue samples. However, as briefly discussed herein, aside from some concerns relating to the specificity of the TUNEL assay itself, it was demonstrated some twenty years ago that the early stages of apoptosis, detected by TUNEL, can be reversed. More recently, compelling evidence from different biological systems has revealed that cells can recover from even late stage apoptosis through a process called anastasis. Specifically, such recovery has been observed in cells exhibiting caspase activation, genomic DNA breakage, phosphatidylserine externalization, and formation of apoptotic bodies. Furthermore, there is solid evidence demonstrating that apoptotic cells can promote neighboring tumor cell repopulation (e.g., through caspase-3-mediated secretion of prostaglandin E2) and confer resistance to anticancer therapy. Accordingly, caution should be exercised in the interpretation of results obtained by the TUNEL and other apoptosis assays (e.g., caspase activation) in terms of apoptotic cell demise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 1×
“Some of the pros and cons of the use of the TUNEL assay in cell-death related studies have been reviewed elsewhere [42].”
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 2×
“Accordingly, the TUNEL assay [39,40] (the pri ciples of which will be outlined below in Section 6) has become the gold standard for detecting cell death through apoptosis.”
MethodGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836 · cited 1×
“Cancer cells triggered to undergo apoptosis also show DNA strand breakage/nuclear fragmentation both at early and late stages of the apoptotic process [8,37,38].”
BackgroundGalluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886 · cited 1×
“[56] to stimulate tumor cell repopulation during cancer radiotherapy.”
BackgroundApoptotic cell-derived exosomes: messages from dying cells
Kakarla, R., Hur, J., Kim, Y. J., Kim, J., & Chwae, Y.-J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0362-8 · Cited by 347 · cited 3×
“Cancer cells undergoing stress-induced premature senescence exhibit persistent levels of DNA strand breaks [28,32]; under some circumstances, escape from premature senescence can lead to the formation of PGCCs and PGCC-acquired stemness [14,33–35], which involves nuclear Figure 2.”
BackgroundKanoh, M., Takemura, G., Misao, J., Hayakawa, Y., Aoyama, T., Nishigaki, K., Noda, T., Fujiwara, T., Fukuda, K., Minatoguchi, S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.21.2757 · Cited by 320
Labi, V, & Erlacher, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.20 · Cited by 295
Tang, H. L., Tang, H. M., Mak, K. H., Hu, S., Wang, S. S., Wong, K. M., Wong, C. S. T., Wu, H. Y., Law, H. T., Liu, K., et al. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-11-0926 · Cited by 293 · cited 2×
“• Recovered cancer cells display an increased number of micronuclei and chromosomal abnormalities that can lead to increased aneuploidy [38,45], a driving force of aggressive disease.”
BackgroundTherapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
The mitochondrial death pathway: a promising therapeutic target in diseases
Gupta, S., Kass, G. E. N., Szegezdi, E., & Joseph, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00697.x · Cited by 278 · cited 1×
“• Given that the process of mitochondrial outer membrane permeabilization (MOMP) has been considered to represent the point-of-no-return for many cell types triggered to undergo apoptosis [53], it has been proposed that perhaps anastasis might occur at early stages of apoptosis and only in cells exhibiting low levels…”
BackgroundCaspase-3 Promotes Genetic Instability and Carcinogenesis
Liu, X., He, Y., Li, F., Huang, Q., Kato, T. A., Hall, R. P., & Li, C.-Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.003 · Cited by 263
In Situ Detection of Apoptosis by the TUNEL Assay: An Overview of Techniques
Loo, D. T. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60327-409-8_1 · Cited by 260 · cited 1×
“As pointed out by Loo almost a decade ago [67], “because TUNEL staining is nonspecific in the sense that the assay will label all free 3′-hydroxyl termini, irrespective of the molecular mechanisms that led to the development of these termini, TUNEL staining will also detect non-apoptotic cells—including necrotic degen…”
BackgroundTumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy.
Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3437 · Cited by 259
Bollum, F. J. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64634-4 · Cited by 258 · cited 1×
“The DNA polymerase that we now know as TdT was initially isolated by Frederick Bollum in 1960 from a calf thymus gland [61].”
BackgroundPuig, P., Guilly, M., Bouchot, A., Droin, N., Cathelin, D., Bouyer, F., Favier, L., Ghiringhelli, F., Kroemer, G., Solary, E., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.04.021 · Cited by 253
GORCZYCA, W., BRUNO, S., DARZYNKIEWICZ, R., GONG, J., & DARZYNKIEWICZ, Z. (1992) · International Journal of Oncology · doi:10.3892/ijo.1.6.639 · Cited by 250
Terminal deoxynucleotidyl transferase: The story of a misguided DNA polymerase
Motea, E. A., & Berdis, A. J. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.06.030 · Cited by 245 · cited 2×
“, with duplex DNA, thus directing its activity towards single-stranded DNA substrates [62,63].”
BackgroundFogarty, C. E., & Bergmann, A. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.47 · Cited by 235 · cited 1×
“, [1,60,74,75]) and other high impact journals (e.”
BackgroundTwo-Step Senescence-Focused Cancer Therapies
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.006 · Cited by 222
Neosis: A Novel Type of Cell Division in Cancer
Sundaram, M., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, R. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.663 · Cited by 207
Senolytics and senostatics as adjuvant tumour therapy
Short, S., Fielder, E., Miwa, S., & von Zglinicki, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.056 · Cited by 202
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J., & Harding, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 192
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
Amend, S. R., Torga, G., Lin, K., Kostecka, L. G., de Marzo, A., Austin, R. H., & Pienta, K. J. (2019) · The Prostate · doi:10.1002/pros.23877 · Cited by 189
Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells
Sliwinska, M. A., Mosieniak, G., Wolanin, K., Babik, A., Piwocka, K., Magalska, A., Szczepanowska, J., Fronk, J., & Sikora, E. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.011 · Cited by 178
Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal
Erenpreisa, J., & Cragg, M. S. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-92 · Cited by 170
Gudipaty, S. A., Conner, C. M., Rosenblatt, J., & Montell, D. J. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060748 · Cited by 165 · cited 2×
“The process of recovery from the brink of apoptotic death is now being referred to as anastasis (Greek for “rising to life”) and appears to involve physiological healing processes that could also sustain damaged cells inappropriately, leading to genetic alterations and transformation [26,27,52].”
BackgroundPolyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer
Chen, J., Niu, N., Zhang, J., Qi, L., Shen, W., Donkena, K. V., Feng, Z., & Liu, J. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009618666180703154233 · Cited by 164
Linking genomic reorganization to tumor initiation via the giant cell cycle
Niu, N., Zhang, J., Zhang, N., Mercado-Uribe, I., Tao, F., Han, Z., Pathak, S., Multani, A. S., Kuang, J., Yao, J., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.75 · Cited by 164
Early stages of p53-induced apoptosis are reversible
Geske, F. J., Lieberman, R., Strange, R., & Gerschenson, L. E. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400786 · Cited by 159 · cited 7×
“[8,41] in a mouse model, in the past decade, our understanding of this phenomenon in different biological systems and its implications in health and disease has increased at a rapid pace.”
BackgroundMethodInfluentialGenome chaos: Survival strategy during crisis
Liu, G., Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, K., Bremer, S. W., Ye, C., Chen, D. J., & Heng, H. H. (2013) · Cell Cycle · doi:10.4161/cc.27378 · Cited by 156 · cited 1×
“, through polyploidy, multinucleation, and/or senescence) [7]; and (iii) cancer cell micronucleation associated with genome chaos, a complex cancer cell survival strategy during crisis [13].”
BackgroundPolyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence
Mosieniak, G., Sliwinska, M. A., Alster, O., Strzeszewska, A., Sunderland, P., Piechota, M., Was, H., & Sikora, E. (2015) · Neoplasia · doi:10.1016/j.neo.2015.11.008 · Cited by 155
A molecular signature for anastasis, recovery from the brink of apoptotic cell death
Sun, G., Guzman, E., Balasanyan, V., Conner, C. M., Wong, K., Zhou, H. R., Kosik, K. S., & Montell, D. J. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201706134 · Cited by 151
Micronuclei and Genome Chaos: Changing the System Inheritance
Ye, C. J., Sharpe, Z. J., Alemara, S., Mackenzie, S., Liu, G., Abdallah, B. Y., Horne, S. D., Regan, S. M., & Heng, H. H. (2019) · Genes · doi:10.3390/genes10050366 · Cited by 142
Anastasis: recovery from the brink of cell death
Tang, H. M., & Tang, H. L. (2018) · Royal Society Open Science · doi:10.1098/rsos.180442 · Cited by 133 · cited 3×
“The process of recovery from the brink of apoptotic death is now being referred to as anastasis (Greek for “rising to life”) and appears to involve physiological healing processes that could also sustain damaged cells inappropriately, leading to genetic alterations and transformation [26,27,52].”
BackgroundReversibility of apoptosis in cancer cells
Tang, H. L., Yuen, K., Tang, H. M., & Fung, M. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604802 · Cited by 129
Eastman, A. R. (2016) · Oncotarget · doi:10.18632/oncotarget.12673 · Cited by 129 · cited 1×
“Since then, numerous other groups have highlighted the potential misinformation perpetuated by the misguided use of cell-based preclinical assays for assessment of cancer cell death; these include large dye uptake assays [2,3], multiwell plate “viability” or “cytotoxicity” assays [3–7], and the colony formation assay…”
BackgroundIn vivo CaspaseTracker biosensor system for detecting anastasis and non-apoptotic caspase activity
Tang, H. L., Tang, H. M., Fung, M. C., & Hardwick, J. M. (2015) · Scientific Reports · doi:10.1038/srep09015 · Cited by 125
Liu, S., Edgerton, S. M., Moore, D. H., & Thor, A. D. (2001) · PubMed · Cited by 122
Micronuclei-based model system reveals functional consequences of chromothripsis in human cells
Kneissig, M., Keuper, K., de Pagter, M. S., van Roosmalen, M. J., Martin, J., Otto, H., Passerini, V., Sparr, A. C., Renkens, I., Kropveld, F., et al. (2019) · eLife · doi:10.7554/elife.50292 · Cited by 111 · cited 2×
“More recently, the TUNEL assay has been used to detect DNA breakage in studies unrelated to cell death [10,11].”
BackgroundMethodTerminal Deoxynucleotidyl Transferase in the Synthesis and Modification of Nucleic Acids
Sarac, I., & Hollenstein, M. (2018) · ChemBioChem · doi:10.1002/cbic.201800658 · Cited by 108 · cited 2×
“, with duplex DNA, thus directing its activity towards single-stranded DNA substrates [62,63].”
BackgroundApoptosis‐induced cancer cell fusion: a mechanism of breast cancer metastasis
Noubissi, F. K., Harkness, T., Alexander, C. M., & Ogle, B. M. (2015) · The FASEB Journal · doi:10.1096/fj.15-271098 · Cited by 105
To the edge of cell death and back
Gong, Y., Crawford, J. C., Heckmann, B. L., & Green, D. R. (2019) · The FEBS Journal · doi:10.1111/febs.14714 · Cited by 105 · cited 5×
“These include: (i) apoptosis in cells that undergo the above-mentioned anastatic recovery process [27]; and (ii) apoptosis in cells that stimulate proliferation of neighboring cells through secreted factors [25].”
BackgroundInfluentialSelf-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells
Liu, X., Li, F., Huang, Q., Zhang, Z., Zhou, L., Deng, Y., Zhou, M., Fleenor, D. E., He, W., Kastan, M. B., et al. (2017) · Cell Research · doi:10.1038/cr.2017.41 · Cited by 103 · cited 1×
“, triggered by self-inflicted DNA breakage [54]), as well as after treatment with external stressors, such as exposure to various doses of ionizing radiation ranging from 0.”
BackgroundNumber of apoptotic cells as a prognostic marker in invasive breast cancer
de Jong, J. S., van Diest, P. J., & Baak, J. P. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0928 · Cited by 99
Cheng, J., Tian, L., Ma, J., Gong, Y., Zhang, Z., Chen, Z., Xu, B., Xiong, H., Li, C., & Huang, Q. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.024 · Cited by 88
Kaur, E., Rajendra, J., Jadhav, S., Shridhar, E., Goda, J. S., Moiyadi, A. V., & Dutt, S. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv050 · Cited by 84
Molecular signature of anastasis for reversal of apoptosis
Tang, H. M., Talbot, C. C., Fung, M. C., & Tang, H. L. (2017) · F1000Research · doi:10.12688/f1000research.10568.2 · Cited by 81
Mirzayans, R., & Murray, D. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041308 · Cited by 79 · cited 5×
“For further details, please consult References [7,18].”
BackgroundSelf-citationDíaz-Carballo, D., Saka, S., Klein, J., Rennkamp, T., Acikelli, A. H., Malak, S., Jastrow, H., Wennemuth, G., Tempfer, C., Schmitz, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1861 · Cited by 79
Giants and monsters: Unexpected characters in the story of cancer recurrence
(2020) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.03.001 · Cited by 78 · cited 2×
“For further details, please consult References [7,18].”
DNA repair is activated in early stages of p53-induced apoptosis
Geske, F. J., Nelson, A. C., Lieberman, R., Strange, R., Sun, T., & Gerschenson, L. E. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400663 · Cited by 77 · cited 4×
“Geske and colleagues reported a series of experiments in 2000 [41] and 2001 [8] designed to determine whether early manifestations of apoptosis could be reversed in a mouse mammary carcinoma cell line.”
BackgroundMethodInfluentialZhao, R., Kaakati, R. N., Lee, A. K., Liu, X., Li, F., & Li, C. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9736-y · Cited by 71 · cited 2×
“[25], “one important clinical implication of these discoveries is that current anti-oncogenic therapies aimed at activating caspases to kill cancer cells are at best a flawed strategy.”
BackgroundQ&A: Cellular near death experiences—what is anastasis?
Sun, G., & Montell, D. J. (2017) · BMC Biology · doi:10.1186/s12915-017-0441-z · Cited by 70
Zhang, X., Ye, C., Sun, F. Z., Wei, W.-J., Hu, B., & Wang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155725 · Cited by 66 · cited 3×
“Cancer cells undergoing stress-induced premature senescence exhibit persistent levels of DNA strand breaks [28,32]; under some circumstances, escape from premature senescence can lead to the formation of PGCCs and PGCC-acquired stemness [14,33–35], which involves nuclear Figure 2.”
BackgroundApoptosis Reversal Promotes Cancer Stem Cell-Like Cell Formation
Xu, Y., So, C., Lam, H., Fung, M.-C., & Tsang, S. Y. (2018) · Neoplasia · doi:10.1016/j.neo.2018.01.005 · Cited by 59 · cited 1×
“both in vitro and in vivo when compared with the parental (pretreatment) cells [50,51].”
BackgroundGregory, C. D., & Paterson, M. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0003 · Cited by 57
Loc'h, J., & Delarue, M. H. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.03.019 · Cited by 56 · cited 1×
“TdT, however, does appear to be capable of some template-dependent activity [64].”
BackgroundStrategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Tang, H. L., Tang, H. M., Hardwick, J. M., & Fung, M. C. (2015) · Journal of Visualized Experiments · doi:10.3791/51964 · Cited by 50 · cited 3×
“, MDA-MB-231 breast carcinoma) [51], and no p53 (e.”
BackgroundMolecular profiling of anastatic cancer cells: potential role of the nuclear export pathway
Seervi, M., Sumi, S., Chandrasekharan, A., Sharma, A. K., & Santhoshkumar, T. R. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00451-1 · Cited by 47 · cited 1×
“Seervi and associates tested this possibility in human cervical (HeLa) and breast (MDA-MB-231) cancer cell lines after treatment with the chemotherapeutic drugs paclitaxel and etoposide [47].”
BackgroundKordon-Kiszala, M., Zarębski, M., Solarczyk, K. J., Ma, H., Pederson, T., & Dobrucki, J. W. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1118 · Cited by 46 · cited 1×
“More recently, the TUNEL assay has been used to detect DNA breakage in studies unrelated to cell death [10,11].”
MethodMurray, D. L., & Mirzayans, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165766 · Cited by 44
Self-citationNecrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review
Gkogkou, C., Frangia, K., Saif, M., Trigidou, R., & Syrigos, K. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-120 · Cited by 42
Viability Assessment Following Anticancer Treatment Requires Single-Cell Visualization
Mirzayans, R., Andrais, B., & Murray, D. L. (2018) · Cancers · doi:10.3390/cancers10080255 · Cited by 36
Self-citationMirzayans, R., Andrais, B., & Murray, D. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081679 · Cited by 33 · cited 1×
“Since then, numerous other groups have highlighted the potential misinformation perpetuated by the misguided use of cell-based preclinical assays for assessment of cancer cell death; these include large dye uptake assays [2,3], multiwell plate “viability” or “cytotoxicity” assays [3–7], and the colony formation assay…”
BackgroundSelf-citationHow Specific Is the TUNEL Reaction?
Riedel-Baima, B., & Sticherling, M. (2002) · American Journal of Dermatopathology · doi:10.1097/00000372-200204000-00004 · Cited by 31
Somatic Genomic Mosaicism in Multiple Myeloma
Ye, C. J., Chen, J., Liu, G., & Heng, H. H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00388 · Cited by 12 · cited 1×
“[12], “Cellular heterogeneity can alter emergent properties, and cells that diverge from the average population—outliers—often define the direction of cancer evolution.”
BackgroundHepG2 cells recovered from apoptosis show altered drug responses and invasiveness
Wang, S., Xie, X., Wong, C. S. T., Choi, P. Y., & Fung, M. C. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60042-4 · Cited by 11
Husmann, M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.27 · Cited by 11 · cited 1×
“Since then, numerous other groups have highlighted the potential misinformation perpetuated by the misguided use of cell-based preclinical assays for assessment of cancer cell death; these include large dye uptake assays [2,3], multiwell plate “viability” or “cytotoxicity” assays [3–7], and the colony formation assay…”
BackgroundXu, Y., So, C., Lam, H., Fung, M.-C., & Tsang, S. Y. (2019) · Journal of Visualized Experiments · doi:10.3791/58642 · Cited by 7
Prognostic significance of apoptosis in laryngeal cancer. A quantitative immunomorphological study
Sikorska, B., Wągrowska‐Danilewicz, M., & Danilewicz, M. (2000) · Acta Histochemica · doi:10.1078/0065-1281-00569 · Cited by 6
Cited by
Cao, L., Cui, Z., Zhang, D., Li, Y., Gao, X., Shang, R., Jiang, X.-D., Du, J., & Sun, X. (2024) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c01447 · Cited by 18
Effects of Growth Factors on In Vitro Culture of Neonatal Piglet Testicular Tissue Fragments
Ibtisham, F., Cham, T.-C., Fayaz, M. A., & Honaramooz, A. (2023) · Cells · doi:10.3390/cells12182234 · Cited by 12
Metadata
- Authors
- Mirzayans, R., & Murray, D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-29
- Volume
- 21
- Issue
- 23
- Pages
- 9090
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3107445852
- Cited by
- 224
- References
- 73
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.